Introduction
Major histocompatibiiitycompiex(MHC)class ii molecules are heterodimeric giycoproteins that present peptides derived from foreign antigens to CD4 T helper ceils. Foiiowing biosynthesis, the class ii a and 8 subunits assemble in the endopiasmic reticulum as a nonameric complex with trimers of the nonpolymorphic invariant (I) chain (reviewed by Cresswell, 1994a) . The abl complex then moves to the trans-Goigi, where signals in the cytoplasmic tail of the I chain (Bakke and Dobberstein, 1990 ) divert the complex to endosomeliysosome-like vesicles called MHC class ii compartments (MIfC; Peters et al., 1991) . The I chain also prevents the binding of peptides by the afl dimers (Roche and Cresswell, 1990; Newcomb and Cresswell, 1993a) until they reach the MIIC, where the I chain is degraded (Bium and Cresswell, 1988; Marie et al., 1994) . Following I chain proteoiysis, the a8 dimers are loaded with peptides, derived from internalized pathogens or endogenous proteins present within the endocytic pathway, and transported to the ceil surface.
Class ii-restricted antigen processing in a group of mutant human ceil lines (e.g., T2.DR3, .174.DR3, and 9.5.3) is defective in that they cannot process and present intact protein antigens, but can present exogenousiy supplied peptides (Meliins et al., 1990; Ceman et al., 1992) . Although expressed on the ceil surface at wild-type levels, class ii molecules from the mutants are different from those from wild-type ceils in that they lack expression of certain antibody epitopes and dissociate in the detergent SDS (Meiiins et al., 1990; . SDS stability of class II molecules is correlated with peptide binding (Germain and Hendrix, 1991) , suggesting that those isolated from the mutants lack associated peptides. In fact, human leukocyte antigen DR (HtA-DR) molecules in the mutant cell lines are complexed with a set of peptides derived from residues 61-104 of the I chain, class ii-associated invariant chain peptides (CLIP) Sette et al., 1992; Awa and Cresswell, 1994) . The defect in these cell lines is caused by the lack of expression of the MHClinked genes HLA-DMA or HLA-DMB or both (Morris et al., 1994; Fling et al., 1994; Denzin et al., 1994) which encode a class II-like molecule (Kelly et al., 1991) . Unlike classical class II molecules, HLA-DM is not expressed on the cell surface, but is localized in the MIIC (Karlsson et al., 1994; Sanderson et al., 1994; Robbins et al., submitted) . Neither HLA-DM nor the murine equivalent, H-2M, significantly associates with the I chain, and their subcellular localization is independent of I chain and class II expression (Denzin et al., 1994; Karfsson et al., 1994) .
Class II CLIP complexes have been found in wild-type ceils, implying that those accumulating in the mutants represent a biosynthetic intermediate in the class Il-processing pathway (reviewed by Cresswell, 1994a) . Class II aj3CLlP complexes can be efficiently loaded with antigenic peptides in vitro by exposure to low pH in the presence of the detergent n-octyl giucoside (GGlc), which induces CLIP removal . Only detergents containing short (8-10 carbon) unbranched carbon chains, such as CeGlc, or aliphatic primary amines or carboxylic acids of a similar size induce CLIP dissociation (Awe and Cresswell, 1994) . Introduction of HLA-DM genes into the mutant ceil lines results in removal of CLIP and efficient peptide loading, suggesting that HLA-DM might be responsible for CLIP removal from the aj3CLlP complex and subsequent peptide binding in vivo. Thiscould occur either directly or by facilitating the trafficking of class II molecules to a compartment where appropriate conditions for CLIP removal exist. In this study, we show that HLA-DM can directly cause CLIP release from aj3CLlP complexes and facilitate the in vitro binding of antigenic peptides.
Results
Incubation of HLA-DM with apCLlP and Peptide
Produces SDS-Stable ag Dimers
The ability of detergents such as CsGlc to induce CLIP dissociation led us to determine whether HLA-DM could perform this function. For convenience, we used HLA-DM precipitated from the class II-negative ceil line TPlDM (Denzin et al., 1994) using agarose beads coupled with the monocionai antibody (MAb) MaP.DMB-C (a mouse MAb specific for the C-terminal region of the HLA-DM6 chain; Robbins et at., submitted). For a negative control, MaP.-DMB-C immunoprecipitates from the HLA-DM-negative ceil line T2 were used. HLA-DR3 aj3CLiP complexes were affinity purified from [~S]methioninslabeled T2.DR3 cells as previously described (Awa and Cresswell, 1994) after extracting the cells in polyoxyethylene 9 lauryl ether (&ES), a detergent that does not facilitate CLIP dissociation. The purified radiolabeled af3CLlP was incubated in Cl& at pH 4.5 for 2 hr at 37OC, wlth either HLA-DM or a control immunoprecipitate and either a HLA-DfWrestritied peptide from Chlamydia major outer membrane protein (MOMP) or a control peptide from hen egg-white lysozyme (HEL). Following neutralization, the samples were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Figure 1A shows that incubation of a5CLlP and MOMP with HLA-DM at low pH (lane 10) resulted in the formation of SDS-stable dimers, indicating peptide loading. Incubation of asCLIP, peptide, and a control immunoprecipitate gave only a low level of SDS-stable dimers (Figure 1 A, lane 9). SDS-stable dimers were only formed in the presence of the HLA-DW-restricted peptide (Figure lA, compare lanes 9 and 10 with lanes 11 and 12). HLA-DM is located in the lysosomal-like MIIC and therefore should be more active at an acidic pH. As expected, incubation of the aSCLIP with HLA-DM and peptide without acidification (Figure 1 A, lanes 7 and 8) resulted in minimal formation of SDS-stable dimers. Incubation of af3CLlP complexes with peptide and CeGlc at acidic pH ( Figure  1 A, lanes 3 and 4) resulted in SDS-stable dimers independent of the presence of HLA-DM. Similar results were obtained with a diff erent DRbrestritied peptide derived from mycobacterial heat shock protein Hsp85 (data not shown).
The useof immunoprecipitated HLA-DM in these assays raises the possibility that other HLA-DM-associated proteins could be influencing the formation of peptide-loaded a5 dimers. Although no HLA-D&associated radiolabeled proteins had been observed in immunoprecipitation experiments (Denzin et al., 1994) we purified HtA-DM from wild-tyg P&la B-lymphoblastoid cell line (B-LCL) to address this question. No contaminating or associated proteins were present in the HLA-DM preparation (Figure 1 B, inset), and it was highly efficient in generating SDS-stable dimers from HLA-DR3 a8CLlP complexes in the presence of added MOMP peptide. Stable dimers were evident after 3 hr at 37OC with as little as 2.5 ng of added HLA-DM. These data show that HlA-DM is intrinsically capable of generating SDS-stabte HLA-DR a8 dimers, requiring no accessory proteins to perform this function.
IAb molecules expressed in the T2 cell line (T2.IAb) are also complexed with the CLIP peptide. Labeled I-Ab af3CLlP complexes were purified from [%S]methioninelabeled T2.lAb cells in C12Ee using an affinity column prepared with the MAb CerCLIP.1, which recognizes CLIPbound class II molecules (Denzin et al., 1994) . The I-Ab CLIP complexes were incubated in the presence and absence of HlA-DM and the I-Ab-restricted Ea peptide and then subjected to SDS-PAGE.
The results ( Figure 1C class II molecules, incubation of I-Ab af3CLlP molecules with 1% CaGlc at acidic pH in the presence of peptide does not result in SDS-stable dimers (Figure lC, lane 1 ). An explanation for this observation may be that mouse I-Ab has a higher affinity for human CLIP than HLA-DR3 (Sette et al., 1995) . Collectively, these experiments showed that incubation of aDCLIP, peptide, and HLA-DM at low pH results in the formation of SDS-stable dimers for both human and mouse class II alleles.
Fractionation
of aSCLIP Complexes into CerCLIP.l-Reactive and Nonreactive Populations Most human B-LCLs have relatively high levels of aDCLIP complexeson their cell surface, as determined by staining with CerCLIP.l (P. C., unpublished data). CLIP bound to HLA-DR3 a/3 dimers in T2.DR3 comprises a nested set of I chain peptides . The high level of aflCLlP complexes on B-LCL could potentially be accounted for by the inability of HLA-DM to remove Cer-CLIP.1 -reactive peptides. To address this, we purified Cer-CLIP.1 -reactive and nonreactive aPCL!P complexes. T2.DFi3 cells were labeled with [%]methionine, and the radiolabeled lysate was sequentially passed over a Cer-CLIP.1 (anti-CLIP) column and then an L243 column (anti-HLA-DR ap dimers) to bind to any aPCLlP not bound by the CerCLIP.l column. Separation by reversed-phase high pressure liquid chromatography (RP-HPLC) demonstrated that the CerCLIP.l -reactive and CerCLIP. 1 -nonreactive aPCLlP preparations contained two different sets of CLIP peptides ( Figure 2A) .
We sequenced three peptides,from RP-HPLC fractions, two CerCLIP.l reactive (eluting at 82 and 88 min) and one CERCLIP.l nonreactive (eluting at 80 min), determining the positions containing [3JS]methionine. The sequence of CLIP (residues 81-104) is LPKPPKPVSKMRMATPLL-MQALPM. With no truncations at the N-terminus, the first two signals should be generated on the eleventh and thirteenth cycles. This pattern was observed for the peaks eluted from the CerCLIP.l-reactive material. The Cer-CLIP.l-nonreactive peak generated signals'on the ninth and eleventh cycles, indicating that this peptide lacked the first two amino acids (data not shown).
The two populations of aDCLIP complexes were incubated at pH 4.5 with either a HLA-DR3-restricted peptide (MOMP) or a control peptide (HEL) in the presence and absence of HLA-DM. Both CerCLIP.l-positive ( Figure 28 , lanes 3 and 4) and CerCLIP.l-negative (lanes 9 and 10) aPCLlP complexes gave increased levels of SDS-stable dimers (lanes 4 and 10). These results suggest that HLA-DM can use a diverse population of CLIP-bound class II molecules as a substrate. The aPCLlP complexes expressed on the surface of wild-type cells may represent a subset that has not passed through the MIIC and therefore has never come in contact with HLA-DM. Alternatively, and perhaps more likely, the level of class II molecules synthesized may be in excess of the amount with which the endogenous HLA-DM molecules can effectively deal.
HLA-DM Is Most Active at Acidic pH To determine the optimal pH for HLA-DM activity, we incubated [Yilmethionine-labeled HLA-DR3 aSCLIP complexes at 37% for 2 hr with MOMP peptide and HLA-DM immunoprecipitates at a range of pH values from 4.5 to 8.0. Following neutralization, the samples were separated by SDS-PAGE.
Quantitation of the percentage of SDSstable dimers formed at each pH by image analysis showed that HLA-DM was most active between pH 5 and pH 8 ( Figure 3A ), a range characteristic of MllCs (Peters et al., 1991) . Control reactions at pH 8.0 and pH 4.5 in the absence of HLA-DM showed almost no SDS-stable dimer at pH 8.0 and only a small amount at pH 4.5. For comparison, we also performed the pH titration in the absence of HLA-DM but in the presence of 1% CsGlc. In contrast with the wide functional pH range observed for HLA-DM, SDS-stable dimers were only efficiently generated at pH 4.5 in CsGlc ( Figure 3B ).
Kinetics of SDS-Stable ap Dimer Induction by HLA-DM In Vitro
In wild-type B-LCL, HLA-DM expression is much lower than that of classical class II molecules, suggesting that HLA-DM must function catalytically. To determine the rate at which HLA-DM could convert aSCLIP complexes to SDS-stable dimers, radiolabeled GerCLIP.l -purified HLA-DR3 aDCLIP and MOMP peptide were added to HLA-DM or control immunoprecipitates and incubated at pH 4.5 for periods up to 10 hr at 37OC. SDS-PAGE analysis of the kinetics of SDS-stable dimer formation is quantitated in Figure 4 . In the presence of HLA-DM, SDS-stable dimers can be detected after only 5 min of incubation at 37OC and formation proceeds rapidly for the first 2 hr of incubation, finally leveling off at 8 hr. During the 10 hr incubation period, 70% of the aSCLIP was converted to an SDS-stable dimer with a tH approximately equal to 1.25 hr. Some SDSstable dimers do form without HlA-DM, which is probably a result of spontaneous CLIP dissociation from the aSCLIP complex, followed by peptide binding. However, dimer formation is substantially slower with a ta,+ of greater than 10 hr (Figure 4) . Overall, the data agree well with a catalytic function for the HLA-DM protein in converting af3CLlP and peptide into SDS-stable dimers, assuming that af3CLlP is in excess of HLA-DM (see Discussion). 
HLA-DM Removes CLIP from HLA-DR3 aSCLIP Complexes
The fact that HLA-DM can substitute for CsGlc in the in vitro peptide loading assay (see Figure 1) suggests that HLA-DM may function by inducing the dissociation of the CLIP peptide, allowing subsequent peptide binding. To determine whether HLA-DM causes CLIP release, we incubated radiolabeled HLA-DR3 a5CLlP (CerCLIP.l purified) with either HLA-DM or control immunoprecipitates in the presence of no peptide or MOMP at pH 4.5 for 8 hr at 37OC. Following neutralization, the af3CLlP complexes and a5 dimers were separated from free CLIP using concanavalin (Con) A-Sepharose beads. Analysis of the supernatants by immunoprecipitation with CerCLIP.l beads followed by SDS-PAGE and fluorography showed that HLA-DM induced the dissociation of CLIP from HLA-DR3 af3CLlP complexes in the presence or absence of MOMP (data not shown). CLIP liberated by HLA-DM in the absence of MOMP was also examined by RP-HPLC after elution from the CerCLIP.l beads by the addition of 10% acetic acid. At least four different CLIP peptides were initially complexed to the afl dimers ( Figure 5A ). RP-HPLC analysis of CLIP removed by HLA-DM showed an identical profile. In the absence of HLA-DM, only a small amount of dissociated CLIP was observed by RP-HPLC analysis. These data, together with those presented in Figure 2 , suggest that all CLIP peptides associated with HLA-DR3 are dissociated by HLA-DM.
If the only function of HlA-DM is to facilitate CLIP dissociation, then the rate-limiting step for SDS-stable dimer formation should be CLIP removal. Figure 4 shows that the generation of SDS-stable dimers in the in vitro assay system was rapid; this experiment, however, did not determine whether CLIP removal was the rate-limiting step. Radiolabeled HLA-DR3 af3CLlP complexes at pH 4.5 were therefore incubated at 37OC for various periods of time with or without HLA-DM. Following neutralization, the free CLIP peptide was immunoprecipitated as described above and analyzed by SDS-PAGE. The kineticsof CLIP release were also determined in the presence of 1% CsGlc and 1% CsGlc plus HLA-DM. Results of these experiments are shown in Figures 5B and 5C. CLIP release was detected after 30 min of incubation and steadily increased throughout the incubation period. The rate of CLIP release in the absence of peptide (th, -1 hr) was similar to that of SDSstable drmer formatron (t,,+, -1.25 hr; see Figure 4 ). This indicates, first, that there is no substantial lag between CLIP release and peptide binding and, second, that CLIP removal and peptide loading may be coupled (see below). HLA-DM did not further accelerate CLIP dissociation induced by CsGlc ( Figure EC) , which was much more rapid and complete than that induced by HLA-DM alone.
CerCLIP.1 Blocks the HLA-DM-Induced Formation of SDS-Stable afi Dimers Since HLA-DM can induce CLIP dissociation, it seems reasonable to propose that HLA-DM directly interacts with a6CLlP complexes. The CerCLIP.l antibody, recognizing the N-terminus of CLIP, might block the interaction and prevent CLIP release. CerCLIP.l-purified HLA-DR3 up-CLIP complexes were therefore preincubated with Cer-CLIP.1 for 30 min at 37OC to allow binding. The antibodyaf3CLlP mixture was then added to MOMP peptide and a HLA-DM immunoprecipitate, and the pH was lowered to 6.0, a pH at which HLA-DM is active (see Figure 3) and antibody can bind, for 3 hr at 37OC. The reactions were terminated by neutralization and analyzed by SDS-PAGE. The results ( Figure 6A, lanes l-3) show that preincubation of a5CLlP with no antibody or with a nonspecific MAb followed by incubation with HLA-DM and peptide at pH 6.0 HLA-DR a6-CLIP complexes purified from a T2.DR3 cell lysate with a CerCLIP.1 column were added to HlA-DM or control immunoprecipitates in the absence of MOMP peptide. Following acidification and incubation at 37OC for 6 hr, the samples were neutralized and the HLA-DR a5 dimer was removed with Con A-Bepharose.
Free CLIP was immunoprecipitated from the supernatant with CerCLIP.l beads, 10% acetic acid was added, and the dissociated CLIP was sep arated by RP-HPLC.
Total CLIP bound to the starting material and released by 10% acetic acid was used as a positive control and is labeled Total. resulted in 45% and 39.6% SDS-stable dimer formation, respectively ( Figure 6B ). Preincubation with CerCLIP.l reduced stable dimer formation to 15.4%. To ensure that the blocking we observed with CerCLIP.l reflected inhibition of HLA-DM function, we determined its effect on peptide loading mediated by CaGlc and also with a6CLlP that had been depleted of CerCLIP.l -reactive complexes. These results ( Figure 6A , lanes 4-9; Figure 6B ) showed that CerCLIP. 1 is not able to block the CsGlc-induced formation of SDS-stable dimers, which, although significant, is low at pH 6.0 (see Figures 3A and 38) or the HLA-DMinduced formation of SDS-stable dimers from CerCLIP.lnonreactive af3CLIP.
HLA-DM Modulates Peptlde Loading In Vitro
Although HlA-DM can remove CLIP from uPCLIP complexes (see Figure 5) , creating peptide-receptive a6 dimers, it could potentially facilitate peptide loading by a more direct mechanism. To test this hypothesis, we titrated the amount of peptide required to generate SDSstable dimers from HLA-DR3 af3CLlP complexes facilitated by either CsGlc or HLA-DM. Radiolabeled af3CLlP complexes were incubated with HLA-DM or control immunoprecipitates, in the presence or absence of 1% CsGlc, with decreasing concentrations of MOMP (5000 nM to 1.6 nM) or no peptide. Following acidification and incubation for 3 hr at 37°C the samples were neutralized, analyzed by SDS-PAGE, and quantitated by image analysis. Halfmaximal peptide loading by HLA-DM was achieved at 5 nM peptide (Figure 7) which is a 160-fold lower concentration than that required for CeGlc (600 nM peptide). Since CLIP release from the aSCLIP complex by CsGlc is more effi- HLA-DR3 a6CLlP complexes were preincubated with CerCLIP.1, a control MAb, GAP.A3, or no MAb for 30 min at 37OC and then added to MOMP peptide and HLA-DM immunoprecipitates or to control immunoprecipitates and the detergent, CsGlc (1% final concentration).
The pH was lowered to 6.0 for 3 hr at 37OC, and the samples were neutralized and analyzed by SDS-PAGE. cient than CLIP release by HLA-DM (see Figures 58 and 5C) but peptide loading is more efficient in the presence of HLA-DM than 1% CsGlc, it seems likely that HLA-DM is directly involved in the peptide loading of the class II a8 dimer. The alternative hypothesis, that CeGlc has an inhibitory effect on peptide binding while it effectivelyfacilitates CLIP release, is negated by the observation that loading in CsGlc with HLA-DM is more efficient than in CsGlc alone (Figure 7 ).
Alternative
Forms of Class II Molecules as HLA-DM Substrates Intermediates in I chain proteolysis other than CLIP have been observed in association with class II molecules. These fragments contain both the transmembrane region and cytoplasmic domain (Pieters et al., 1991; Marie et al., 1994; Amigorena et al., 1995 monensin (Machamer and Cresswell, 1984) or leupeptin (Blum and Cresswell, 1988) , respectively. Radiolabeled aBLIP, a8l, or a8CLlP complexes were added to HLA-DM or control immunoprecipitates and MOMP at pH 4.5. After incubation at 37X for3 hr and neutralization, the samples were analyzed by SDS-PAGE. Surprisingly, HLA-DM induced the generation of SDS-stable a8 dimers from a8LlP ( Figures 8A and 8B ), causing about a P-fold increase. This effect was reproducible in three separate experiments. For a8l, no difference was observed, indicating that a81 cannot serve as a substrate for HLA-DM ( Figures 8A and  88 ). HLA-DR3 a8CLlP was a better substrate for HLA-DM than abLIP, since a 3-fold increase in the level of SDSstable dimers was observed, compared with only a 2-fold increase for a8LlP ( Figure 8B ). LIP is clearly visible on the gel in Figure 8A after incubation with HLA-DM, suggesting that proteolysis during the incubation is not occurring and that a8LlP may be a genuine substrate. However, it is possible that a8 dimers associated with smaller I chain fragments (Marie et al., 1994 ) may be present and that these are the true substrates.
To determine whether HLA-DM can also remove endogenous peptides from mature class II a8 dimers, HLA-DR3 a3 dimers were affinity purified using an L243 column from metabolically labeled wild-type Pala cells. The HLA-DR3 a8 dimers were added to HLA-DM or control immunoprecipitates in the presence or absence of MOMP. The reaction mixtures were acidified, incubated at 37OC for 3 hr, neutralized, analyzed by SDS-PAGE, and quantitated by image analysis. The results argue that HLA-DM is unable to remove peptides from mature class II molecules, because incubation in the absence of peptide did not reduce the amount of SDS-stable dimers ( Figure BC , compare lanes 3 and 4; Figure 8D ). Incubation of the a8 dimers with HLA-DM and MOMP did result in a small increase in SDS-stabledimers(from57.4% to85.5%; Figure8D) . This is probably due to a small population of a8CLlP complexes in the af3 dimers purified from the wild-type cells. 
Discussion
A number of hypothetical mechanisms for the action of HLA-DM have been suggested (Cresswell, 1994b; Fling et al., 1994; Morriset al., 1994) . These include thepossibilities that HLA-DM may function as a chaperone, escorting immature a9 dimers to the appropriate environment where peptides are available; that HLA-DM may bind peptides in a lysosomal compartment and deliver them to available class If molecules in a different compartment; that HLA-DM may function as a'sinK for CLIP, thus driving an equilibrium from a3CLlP to empty a3 dimers, which would then be receptive to peptides; or that HLA-DM might actively induce CLIP dissociation. The data presented here agree with the last hypothesis. Thus, HLA-DM under mildly acidic in vitro conditions induces CLIP dissociation from aSCLIP and, in the presence of a suitable antigenic peptide, SDSstable af3-peptide complexes are efficiently generated. None of the other three suggestions is totally invalidated by the data presented here, although no evidence was found for CLIP association with HLA-DM after incubation with af3CLlP (data not shown), which would argue against the CLIP sink hypothesis. A variant of that hypothesis that suggests that HLA-DM might have peptidase activity and thus drive an equilibrium from aDCLIP to empty a9 dimers by degrading CLIP is also not supported by the data. Figure 5A shows that the RP-HPLC profile of CLIP released by HLA-DM is identical to the profile of CLIP initially associated with the aSCLIP complex. Thus, the data clearly indicate that HLA-DM in some way actively induces CLIP dissociation from afXLlP complexes. To be completely satisfactory, any scheme proposed to explain the mechanism of action of HLA-DM should incorporate the finding that CeGlc, similar detergents, or primary aliphatic amines and carboxylic acids can also facilitate CLIP dissociation and the generation of peptideloaded SDS-stable dimers (Awa and Cresswell, 1994) . A model that potentially fulfills this criterion is presented in Figure 9 . The model argues that af3 dimers associated with CLIP can occur in two conformations, one of which, a9*, has a low affinity for CLIP and is the target for both the detergent effect and HlA-DM. At neutral pH, the equilibrium strongly favors the high affinity form. At lower pH, the equilibrium shifts toward the low affinity form. CaGlc or similar detergents preferentially act upon af3*CLIP, facilitating CLIPdissociation. ThisgeneratesfreeaS*, which binds available peptkfes and generates a stable af3-peptide complex. The detergent effect is not seen in the case of I-Ab CLIP complexes (Figure lC) , which suggests that susceptibility to detergent-induced CLIP dissociation is not a universal feature of class II molecules. We have previously suggested a relationship between the ability of primary aliphatic chains to disrupt aSCLIP association and the SDS instability of af3CLlP (Awa and Cresswell, 1994) . Interestingly, I-Ab molecules from T2.l-Ab show the presence of substantial amounts of "fk)ppy" SDS-stable dimers (Sadegh-Nasseri and Germain, 1991) indicated by the arrowhead in Figure lC 1A and 1 B). The correlation between lack of susceptibility to CaGlc-induced CLIP dissociation and the presence of floppy SDS-stable dimers is in agreement with this hypothesis if one assumes that the floppy I-Ab dimers are af.XLlP complexes rather than empty afi dimers. Conceivably, however, the floppy dimers may be empty, perhaps because of some CLIP dissociation under the alkaline elution conditions used in affinity purification. The amount of floppy dimers is unchanged in the presence of peptide and HLA-DM (Figure lC) , indicating that they may not be a good substrate and perhaps suggesting that the presence of class II-bound CLIP is required for HLA-DM function. These questions remain to be investigated.
HLA-DM, in the proposed model, transiently binds aj3*-CLIP causing CLIP release, facilitates peptide association with the empty ajj* dimers, and then repeats the process with additional aP*CLIP complexes, thus catalyzing peptide loading. While no physical evidence for a class II-HLA-DM interaction is currently available, the ability of CerCLIP.l to block HLA-DM-mediated peptide loading of aj3CLlP complexes ( Figures 6A and 6B) suggests that a transient physical interaction must occur. The size of an antibody molecule precludes a precise determination of the class II-HLA-DM interaction site based on the ability of CerCLIP.l to block HLA-DM-induced CLIP dissociation. However, consistent with previous suggestions that CLIP associates with polymorphic regions of class II molecules (Sette et al., 1995; Awa and Cresswell, 1994; Malcherek et al., 1995) it has recently been shown that it binds like a conventional peptide with the CerCLIP.l-reactive N-terminus at one end of the binding groove, corresponding to the C-terminal end of the 51 a helix and the N-terminal end of the al a helix (Ghosh et al., submitted). HLA-DR3 afi dimers containing a mutant a chain with an additional N-linked glycan at position 94 in the a2domain accumulate as a9CLlP complexes, even in HLA-DM-positive cells . This site is almost directly below the end of the binding groove occupied by the N-terminus of CLIP (J. Park and D. Wiley, personal communication). The inhibitory effect of the novel glycan and that of CerCLIP.l could therefore be explained if HtA-DM interacts laterally with that face of the class II molecules. This hypothesis clearly requires further testing. Incorporated into the model (Figure 9 ) is the idea that peptide association with the a$ dimer following CLIP dissociation occurs prior to HLA-DM dissociation. We have no evidence in favor of this, except the observation that peptide loading in the presence of CsGlc is more efficient when HLA-DM is added (Figure 7) . If HLA-DM simply facilitated the generation of empty af3*, as shown for CaGlc, then one would not expect this enhanced efficiency. One explanation is that empty class II molecules transiently associated with HLA-DM have a higher affinity for peptides other than CLIP than do free empty afi dimers. Alternatively, HLA-DM could play a more direct role as a peptide donor. In experiments in which we have isolated HLA-DM molecules from [35S]methionine-labeled B-LCL, we have been unable to demonstrate associated [YS]methioninelabeled peptides by acid elution and RP-HPLC analysis (L. K. D. and P. C., unpublished data). However, methionine is a relatively uncommon amino acid in proteins, and we cannot say that we have unambiguously shown that HLA-DM does not bind peptides.
The final stage of the generation of ap-peptide complexes shown in Figure 9 indicates that the a5-peptide complex dissociates from HLA-DM, freeing the HLA-DM molecule for further interactions with afXLIP. That mature a5 peptide complexes are themselves poor substrates for HlA-DM is shown in Figure 8 , which, based on the hypothetical scheme shown, we would interpret by arguing that any equilibrium involving these complexes would heavily favor the aj3 form as opposed to the afl' form. The data clearly fit with observations favoring a role for newly synthesized class II molecules, as opposed to recycling class II molecules, in class II-restricted antigen processing.
The suggestion that HLA-DM repeatedly interacts with aj3CLlP complexes, in an essentially catalytic role, is based on a number of findings. First, HLA-DM has a long t/n in vivo (Denzin et al., 1994) arguing that it is not consumed during peptide loading. Second, HLA-DM is present in low amounts relative to HLA-DR in B-LCL. Based on comparative labeling efficiencies, relative yields following affinity purification, and Western blotting experiments, we estimate that the total HLA-DM expressed in B-LCL is less than 5% of the total HLA-DR. The majority of the assays performed in this work involved the addition of a5CLlP complexes isolated from approximately 0.5 x 1 OsT2.DR3 cells, which express wild-type levels of HLA-DR3 on the Cell surface, to HLA-DM immunoprecipitated from 1 O8 T2/ DM cells. Thus, the af3CLlP complexes are clearly in excess. In addition, 2.5 ng of purified HLA-DM, equivalent to 0.6 x lo6 wild-type cells based on purification yields, gave 19% SDS-stable dimers using af3CLlP from 0.5 x 1 06T2.DR3 cells in 3 hr at 37OC (Figure 1 B) . This increased e-fold after 18 hr of incubation at 37X (data not shown), suggesting that HLA-DM is functioning substoichiometritally and therefore catalytically.
Perhaps the most surprising finding is the observation that HLA-DR af3LlP complexes may serve as a HLA-DM substrate ( Figures 8A and 88) . No CLIP is visible in the aDLIP preparations ( Figure 8A ), arguing that contaminating aj3CLlP cannot be the source of the HLA-DM-induced SDS-stable dimers. Low M, I chain fragments, running on the dye front in Figure 8A , might ba associated with a subset of the af3 dimers, and these complexes could be the true substrates. However, the data suggest that aj3LlP is probably a HLA-DM substrate and clearly show that af3l is not a substrate. It is possible that intact I chain blocks the interaction of ap with HlA-DM, whereas LIP does not, and the C-terminal region of the I chain missing from LIP may be responsible for this. Combined with the CerCLIP.l blocking data ( Figure 6 ) this might suggest that the C-terminal region of the I chain associates with the region of the al and 51 domains of the af3 dimer closest to where the N-terminus of CLIP is located. A potential complicating factor, however, is that apI complexes are stable nonamers (Roche et al., 1991) whereas aDLIP complexes in solution can dissociate into a5LlP trimers (Newcomb and Cresswell, 1993b) . Clearly, the accessibility of a3 dimers involved in a nonameric structure may be quite different from that in a simple trimeric structure.
It has been shown that asLIP complexes accumulate in dense compartments with sedimentation properties in Percoll gradients similar to MllCs (Marie et al., 1994; Robbins et al., submitted) , which one could simply interpret as an accumulation of af3LlP in the MIIC. However, it remains a possibility that af3LlP complexes accumulate in a different, earlier compartment than the HLA-Dhl-containing MIICs, as suggested by Blum and colleagues (Marie et al., 1994) but that the two compartments have similar densities. Further cleavage of the I chain may be required for a9 dimers to move into MllCs and become accessible to HtA-DM, an idea consistent with the possibility that signals for MIIC localization may be in the ap dimers themselves. This may be the putative signal for endosomal localization in the lumenal region of the class II molecule suggested by the work of Chervonsky et al. (1994) .
Experimental Procedures
Cell Lines
The T x B hybrid cell line ,174 x CEMTP (class II-; T2) (Salter et al., 1966) its derivatives transfected with the HlA-DM genes (T2/DM) (Denzin et al., 1994 ) and the HLA-DR3 genes (T2.DR3) and the EBV-transformed Pala B-LCL (DR3.Dwl7) (Riberdy et al., 1994) have been described elsewhere.
T2 transfected with I-Ab genomic DNAs (T2.FA3 was a gift from Dr. Ned Braunstein, Columbia University. The cell lines were maintained in Iscove's DMEM (GIBCO BRL) with 5% calf serum (GIBCO BRL) in the presence of 5% CO2 at 37OC. The T2/DM cell line was grown in the presence of 500 @ml puromycin (Sigma).
Peptldes
All peptides were synthesized by the Keck Foundation Biotechnology Resource Laboratory (Yale University).
Peptides were purified by RP-HPLC and laser desorption mass spectrometry indicated that all were a single species. The HlA-DRI-restricted peptides MOMP (QASLALS-YRLNMFTP; and Hsp65 (KTIATDEEARR; Geluk et al., 1992) are derived from residues 251-266 of the major outer membrane protein of Chlamydia trachomatis and 3-l 3 of the mycobacterial heat shock protein Hsp65, respectively.
The I-A*-binding HEL peptide (NTDGSTDYGILQINSRY; Babbitt et al., 1965) is derived from residues 46-61 of hen egg lysoxyme.
The Err peptide (FEAQGAfANI-AVD; Rudensky et ?I., 1991) is derived from residues 56-71 of the I-Ea chain and is I-Aa restricted.
Antlbodirs
The hybridoma cell lines t.243 (anti-HLA-DR aj3; Lampson and Levy, 1960), DA6.147 (anti-fitA-DR a chain; Guy et al., 1962) CerCLIP.1 (anti-CLIP24; Denzin et al., 1994) MaP.DMBC (Robbinset al., submitted), and GAP.AS (anti-HLA-A3; Berger et al., 1962) have been described elsewhere. For affinity chromatography and immunoprecipitations with beads, L243, CerCLIP.1, MaP.DMB-C, and normal mouse IgG were coupled to CNBr-activated Biogel AlSm (Bio-Rad) at a concentration of 1 mg of antibody per milliliter of gel.
Affinity Purification of Radiolabeled Class II ap Dimers The affinity purification of ["S]methionine-labeled HLA-DR3 a6 dimers and af3CLlP complexes from Pala B-LCL and T2.DR3 using the MAb L243 was performed as previously described (Awa and Cresswell, 1994) . Purification of I-Ab af3CLlP complexes was similarly performed from [?S]methionine-labeled T2.l.Ab cells using CerCLIP.1 affinity chromatography.
For purification of HLA-DR3 a6CLlP complexes that were CerCLIP.l reactive and nonreactive, a radiolabeled T2.DR3 ly sate was passed twice over a CerCLIP.1 column and then over a L243 column to bind any remaining HLA-DR3 af3CLIP. All columns were eluted with 0.1 M Tris (pH 11.5). 0.1% CIIEO. The eluted fractions were neutralized with 1 M acetic acid and stored at 4OC until use.
HLA-DA3 apI complexes were purified using a DA6.147 column from a cell extract of Pafa cells labeled with PSjmethionine for 4 hr in the presence of IO pM monensin (Sigma) as described previously (Machamer and Cresswell. 1964) . For purification of aj3LlP complexes, an L243 column was used and Pala cells were similarly labeled and then chased for 15 hr in the presence of 0.5 mM leupeptin (Sigma) (Blum and Cresswell, 1966) .
HLA-DM lmmunopreclpltatlons T2/DM or control T2 cells were extracted for 30 min on ice in TS buffer (pH 7.4) containing 1% Triton X-100 (Sigma), 0.5 mM PMSF, 0.1 mM TLCK at 1 x IO to 2 x IO" cells per milliliter. The lysates were pracleared overnight at 4OC with normal rabbit serum and protein A-Sepharose (Sigma) and then incubated with 25-50 pl of MaP.DMB-C beads for 1 hr at 4OC. The beads were washed three times with 0.1% C12E8, TS (pH 7.4) and stored at -20°C until use. Each immunoprecipitate is equivalent to 1 x lo8 cells.
Purlflcatlon of HLA-DM Pala B-LCLs (14 x IO@) were extracted for 30 min on ice in 2% C12E8 in TS (pH 7.4) containing 0.5 mM PMSF and 5 mM iodoacetamide. Glycoproteins were purified by affinity chromatography using Con A-Sepharose 48 (Sigma) and eluting in 0.1% C12Eo in TS (pH 7.4) containing 5% a-methyl mannoside (Sigma). The purified glycoproteins (42 mg) were applied to a MaP.DMB-C affinity column and HLA-DM was eluted in 0.6% CHAPS (Sigma), 0.1 M NaCI, 0.05 M acetate (pH 3.0). Neutralized fractions were analyzed for HLA-DM by Western blotting using a rabbit anti-peptide antibody (R.DMB-C) specific for the HLA-DM6 cytoplasmic domain (Denzin et al., 1994) . Approximately 40 ug of HLA-DM was recovered, which was uncontaminated with additional proteins based on SDS-PAGE and staining with Fast Stain (Zoion Research Inwrporated).
Quantitation was based on amino acid analysis of the purified material.
SDS Stability Assay HLA-DM or control (T2) immunoprecipitates or purified HLA-DM was incubated with 20.000-40,000 cpm of radiolabeled aSCLIP, aSLIP, aj3I, or af3-peptide complexes in TS buffer (pH 8.0) 0.1% C12E0. Specific peptide, control peptide, or no peptide was added, and the pH was adjusted as indicated by the addition of 1 M acetic acid. Where indicated, 1% CsGlc was also included in the reaction mixture. Peptides were used at a concentration of 100 uM in all experiments except for the MOMP titrations (Figure 7) . Following incubation at 37OC for 2-3 hr, samples were neutralized with 1 M Tris, mixed with IO x nonreducing Laemmli sample buffer and separated by SDS-PAGE (10.5%) without boiling. Gels were fixed for 20 min and treated with Enlightening (Dupont New England Nuclear) for 20 min prior to drying and film exposure.
Bands were quantitated with a Bit-Rad 65250 Molecular Imager, subtracting a background obtained by integrating a blank area of the appropriate size on each gel. Antibody blocking experimentswere performed as described above, except that the affinity-purified CerCLIP.l-negative and CerCLIP.lpositive &CLIP complexes were incubated with 2 ug of affinity-purified CerCLIP.1, GAP.AS. or no antibody at 37OC for 30 min before incubation with HLA-DM and antigenic peptide at pH 6.0.
Analysis
of CLIP Disaoclatlon CerCLIP.1 affinity-purified HLA-DR3 af3CLIP complexes were added to HtA-DM or control immunoprecipitations in the presence or absence of MOMP at pH 4.5. At various times, the samples were neutralized with 1 M Tris and diluted to 1 ml with TS (pH 7.4) 0.1% C12E8. Con A-Sepharose beads (100 pl; Sigma) were added, and the tubes were incubated overnight at 4OC to remove the HLA-DR and HLA-DR CLIP complexes.
The Con A-Sepharose beads were pelleted, and the supernatantswere immunoprecipitated with CerCLIP.1 beads (50 ul) and analyzed by SDS-PAGE or RP-HPLC.
RP-HPLC CLIP peptides were eluted from CerCLIP.1 beads by the addition of 10% acetic acid and analyzed by RP-HPLC as previously described (Awa and Cresswell, 1994) . CLIP peptides eluted from a5CLlP cornpfexes by the addition of 10% acetic acid were similarly analyzed. Profiles of labeled peptides were generated from 0.5 ml fractions wllected and analyzed on a liquid scintillation counter.
